In a phase 1 clinical trial, treatment with the investigational bispecific antibody cevostamab reduced cancer in more than 40% of patients with multiple myeloma, many of whom had already undergone multiple other cancer treatments, ...
Jul 22, 2026
0
9
There's good news to report when it comes to women's health. A new study provides encouraging evidence that most clinical trials have substantial female representation relative to disease burden. The study also shows an increase ...
Jul 22, 2026
0
6
In leukemia's most aggressive forms, the blood cell factories in our bone marrow falter. Instead of dividing and multiplying at their usual prolific pace, generating hundreds of billions of new cells daily, some precursor ...
Jul 22, 2026
0
17
Curcumin, berberine and other plant-derived compounds have long attracted scientific interest because of their anti-inflammatory and anticancer properties. A new study by researchers from Wroclaw Medical University and the ...
Jul 22, 2026
0
150
Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, but many tumors remain resistant. A new study from researchers at the Hackensack Meridian Center for Discovery and Innovation (CDI) identifies a previously ...
Jul 22, 2026
0
6
A single preoperative blood sample may help improve the prediction of recurrence or metastasis in patients with colorectal cancer. A joint research team from KAIST, Gangnam Severance Hospital and Asan Medical Center has shown ...
Jul 22, 2026
0
4
University of Virginia Comprehensive Cancer Center scientists have developed a promising new experimental approach to targeting glioblastoma, the most common and deadliest brain cancer. The approach could overcome many of ...
Jul 22, 2026
0
11
Why do cancers develop differently in different people—even when they are exposed to the same risk factors? An international research group, including the German Cancer Research Center (DKFZ), has demonstrated in mice that ...
Jul 22, 2026
0
3
Malignant melanoma is one of the most dangerous forms of cancer. Around half of melanomas and about 7% of all other cancers carry a mutation in a protein called BRAF. This mutation disrupts the regulation of cell division, ...
Jul 21, 2026
0
6
Biological sex factors into cancer in ways you might not expect. In lung cancer, a form called squamous cell carcinoma disproportionately affects male patients, while adenocarcinoma occurs more frequently in female patients. ...
Jul 21, 2026
0
2
